The emerging world of the fungal microbiome

Trends in Microbiology

Volumn 21, Issue 7, 2013, Pages 334-341

  Huffnagle, Gary B ^a   Noverr, Mairi C ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

disease; fungi; health; microbiome; mucosal; yeast

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; IMMUNOSUPPRESSIVE AGENT; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; RIBOSOME DNA;

ATOPIC DERMATITIS; BIOFILM; BIOINFORMATICS; CANDIDA; CANDIDEMIA; CANDIDIASIS; CHRONIC WOUND; CRYPTOCOCCUS; FUNGAL COLONIZATION; FUNGAL DETECTION; FUNGUS; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS TRANSMISSION; GASTROINTESTINAL MUCOSA; HIGH THROUGHPUT SEQUENCING; HUMAN; LACTOBACILLUS; MALASSEZIA; MICROBIOME; MOUTH MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PNEUMOCYSTIS; PRIORITY JOURNAL; PYROSEQUENCING; RESPIRATORY TRACT MUCOSA; REVIEW; SKIN FLORA; STOMACH ULCER;

FUNGI; HUMANS; MICROBIOTA;

BACTERIA (MICROORGANISMS); FUNGI;

EID: 84879786685     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.04.002     Document Type: Review

References (69)

1. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
2. Dethlefsen L., et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008, 6:e280.
3. Sogin M.L., et al. Microbial diversity in the deep sea and the underexplored "rare biosphere". Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12115-12120.
4. Hajishengallis G., et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011, 10:497-506.
5. Hatoum R., et al. Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications. Front. Microbiol. 2012, 3:421.
6. Cassone M., et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J. Clin. Microbiol. 2003, 41:5340-5343.
7. Charlson E.S., et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota following lung transplant. Am. J. Respir. Crit. Care Med. 2012, 186:536-545.
8. Delhaes L., et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS ONE 2012, 7:e36313.
9. Gardes M., Bruns T.D. ITS primers with enhanced specificity for basidiomycetes-application to the identification of mycorrhizae and rusts. Mol. Ecol. 1993, 2:113-118.
10. Ghannoum M.A., et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010, 6:e1000713.
11. Lindsley M.D., et al. Rapid identification of dimorphic and yeast-like fungal pathogens using specific DNA probes. J. Clin. Microbiol. 2001, 39:3505-3511.
12. Kleinegger C.L., et al. Frequency, intensity, species, and strains of oral Candida vary as a function of host age. J. Clin. Microbiol. 1996, 34:2246-2254.
13. Soll D.R., et al. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 1991, 29:1702-1710.
14. Blaschke-Hellmessen R. Habitats for Candida in medical and hygienic respects. Mycoses 1999, 42(Suppl. 1):22-29. (in German).
15. Odds F.C. Ecology and epidemiology of Candida species. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 1984, 257:207-212.
16. Mayer F.L., et al. Candida albicans pathogenicity mechanisms. Virulence 2013, 4:119-128.
17. Fidel P.L. Distinct protective host defenses against oral and vaginal candidiasis. Med. Mycol. 2002, 40:359-375.
18. Yano J., et al. Cytokines in the host response to Candida vaginitis: identifying a role for non-classical immune mediators, S100 alarmins. Cytokine 2012, 58:118-128.
19. Faux J.A., et al. A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency. J. Immunol. Methods 1992, 153:167-172.
20. Noverr M.C., et al. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. 2001, 69:2957-2963.
21. Klotz S.A., et al. Candida albicans Als proteins mediate aggregation with bacteria and yeasts. Med. Mycol. 2007, 45:363-370.
22. De Sordi L., Muhlschlegel F.A. Quorum sensing and fungal-bacterial interactions in Candida albicans: a communicative network regulating microbial coexistence and virulence. FEMS Yeast Res. 2009, 9:990-999.
23. Peleg A.Y., et al. Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 2010, 8:340-349.
24. Kong H.H., Segre J.A. Skin microbiome: looking back to move forward. J. Invest. Dermatol. 2012, 132:933-939.
25. Brunetti L., et al. Surveillance of nosocomial infections: a preliminary study on yeast carriage on hands of healthcare workers. J. Prev. Med. Hyg. 2008, 49:63-68.
26. Chang F.Y., et al. Analysis of the serum levels of fungi-specific immunoglobulin E in patients with allergic diseases. Int. Arch. Allergy Immunol. 2011, 154:49-56.
27. Gaitanis G., et al. The Malassezia genus in skin and systemic diseases. Clin. Microbiol. Rev. 2012, 25:106-141.
28. Fry L., Baker B.S. Triggering psoriasis: the role of infections and medications. Clin. Dermatol. 2007, 25:606-615.
29. Paulino L.C., et al. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol. 2006, 44:2933-2941.
30. Park H.K., et al. Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps. PLoS ONE 2012, 7:e32847.
31. Zhang E., et al. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol. Immunol. 2011, 55:625-632.
32. Sonesson A., et al. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Acta Derm. Venereol. 2013, 93:340-345.
33. Dowd S.E., et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J. Wound Care 2011, 20:40-47.
34. Jenkinson H.F. Beyond the oral microbiome. Environ. Microbiol. 2011, 13:3077-3087.
35. Dickson R.P., et al. The role of the microbiome in lung disease. Exp. Rev. Respir. Med. 2013, 7.
36. Chabe M., et al. Pneumocystis: from a doubtful unique entity to a group of highly diversified fungal species. FEMS Yeast Res. 2011, 11:2-17.
37. Bik E.M., et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:732-737.
38. Savage D.C., Dubos R.J. Localization of indigenous yeast in the murine stomach. J. Bacteriol. 1967, 94:1811-1816.
39. Artwohl J., et al. Population changes of indigenous murine Candida pintolopesii under various experimental conditions and routes of inoculation. Appl. Environ. Microbiol. 1988, 54:2371-2374.
40. Mason K.L., et al. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect. Immun. 2012, 80:150-158.
41. Kumamoto C.A. Inflammation and gastrointestinal Candida colonization. Curr. Opin. Microbiol. 2011, 14:386-391.
42. Yamaguchi N., et al. Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. Gut 2006, 55:954-960.
43. Scupham A.J., et al. Abundant and diverse fungal microbiota in the murine intestine. Appl. Environ. Microbiol. 2006, 72:793-801.
44. Mason K.L., et al. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect. Immun. 2012, 80:3371-3380.
45. Noverr M.C., et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 2004, 72:4996-5003.
46. Iliev I.D., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336:1314-1317.
47. Ott S.J., et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand. J. Gastroenterol. 2008, 43:831-841.
48. de Repentigny L., et al. Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice. Infect. Immun. 1992, 60:4907-4914.
49. Wingard J.R., et al. Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect. Immun. 1980, 29:808-813.
50. Noverr M.C., et al. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 2005, 73:30-38.
51. O'Driscoll B.R., et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin. Exp. Allergy 2009, 39:1677-1683.
52. Seow C.H., et al. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am. J. Gastroenterol. 2009, 104:1426-1434.
53. Vernier G., et al. Relevance of serologic studies in inflammatory bowel disease. Curr. Gastroenterol. Rep. 2004, 6:482-487.
54. Standaert-Vitse A., et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 2006, 130:1764-1775.
55. Jawhara S., et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J. Infect. Dis. 2008, 197:972-980.
56. Hummel R.P., et al. Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse. J. Surg. Res. 1973, 15:53-58.
57. Kennedy M.J. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro. Sabouraudia 1981, 19:205-208.
58. Kennedy M.J., Volz P.A. Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice. Sabouraudia 1983, 21:27-33.
59. Kennedy M.J., Volz P.A. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect. Immun. 1985, 49:654-663.
60. Kennedy M.J., Volz P.A. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 1985, 23:265-273.
61. van der Waaij D. Colonization resistance of the digestive tract-mechanism and clinical consequences. Nahrung 1987, 31:507-517.
62. van der Waaij D., Berghuis J.M. Determination of the colonization resistance of the digestive tract of individual mice. J. Hyg. (Lond.) 1974, 72:379-387.
63. Van der Waaij D., Van der Waaij B.D. The colonization resistance of the digestive tract in different animal species and in man; a comparative study. Epidemiol. Infect. 1990, 105:237-243.
64. Naglik J.R., et al. Animals models of mucosal Candida infection. FEMS Microbiol. Lett. 2008, 283:129-139.
65. Helstrom P.B., Balish E. Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect. Immun. 1979, 23:764-774.
66. Savage D.C. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J. Bacteriol. 1969, 98:1278-1283.
67. Noverr M.C., Huffnagle G.B. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 2004, 72:6206-6210.
68. Wagner R.D., et al. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 2000, 63:638-644.
69. Yamaguchi N., et al. Gastric colonization of Candida albicans differs in mice fed commercial and purified diets. J. Nutr. 2005, 135:109-115.